Organization Profile

You just read:

Libtayo™ (cemiplimab) Receives Positive Recommendation from the pan-Canadian Oncology Drug Review Expert Review Committee for the Treatment of Metastatic Cutaneous Squamous Cell Carcinoma

News provided by

Melanoma Network of Canada

Jan 16, 2020, 08:00 ET